Atracurium besylate, 2,2'-<3 ) l l-dioxo-4,10-diojtatridecylene)-bis-[6,7-dimethoxy-l-(3,4-dimethoxybenzyl)-2-methyl-l^>3,4-tetrahydroisoqiiinoliniuin] dibenzenesulphonatc, is one of a new series of competitive neuromuscular blocking agents. Ani.v. dose of 0.25 mg kg" ' produced complete paralysis in anaesthetized cats, dogs and rhesus monkeys; paralysis was of medium duration and was readily antagonized by neostigmine. Vagal blockade occurred only after doses 8-16 times greater than the full neuromuscular paralysing dose and effects on sympathetic mechanisms were minimal. Hypotension and bradycardia were evident after supramaximal doses of 4 mg kg" ' i.v. and these effects, together with circulatory depression, were probably attributable to histamine release. In vitro studies have shown that the non-enzymic decomposition of atracurium by "Hofrnann Elimination" was enhanced by increasing pH. In vivo neuromuscular paralysis was significantly reduced when the arterial pH was increased. There were indications that neither the liver nor the kidney plays a major role in the metabolism and elimination of unchanged drug. These results are of sufficient interest to merit the cvaluanon of atracurium in anaesthetized man.
All competitive neuromuscular blocking agents currently in general use, in addition to their actions at the neuromuscular junction, inhibit cholinergic transmission at autonomic sites and may produce undesirable cardiovascular sideeffects (Hughes and Chappie, 1976a) . Furthermore, all show a significant increase in the duration of neuromuscular blockade when excretion is inhibited by renal insufficiency (Wingard and Cook, 1977) . Atracurium besylate, 2,2'-(3,11 -dioxo-4,10-dioxatridecy lene)-bi s-[6,7-dimethoxy-l-(3,4-dimethoxybenzyl) -2-methyl-1,23,4-tetrahydroisoquinolinium] dibenzenesulphonate, is one of a new series of neuromuscular blocking agents, which has been developed in an attempt to overcome the disadvantages of such drugs (Stenlake, 1979) .
The chemical structure of atracurium is shown in figure 1 and the arrows indicate the likely metabolic pathways. These are (1) an enzymic ester hydrolysis to give the monoquaternary metabolites and (2) decomposition by what is called "Hofmann Elimination". Under mild alkaline conditions fission occurs at the quaternary nitrogen to give laudanosine as the main metabolite (Stenlake, 1979) . No other available neuromus-OMe OMe FIG. 1. Chemical structure of atracurium; the arrows indicate the likely metabolic pathways.
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Erter Hydrolysis OMe OMe vein as described previously (Hughes and Chappie, 1976a) . The twitch responses of the right gastrocnemius muscle were elicited by stimulation of the sciatic nerve at a frequency of 0.1 Hz with rectangular pulses of supramaximal voltage and 0.1-0.15 ms duration. In most experiments the left gastrocnemius muscle was stimulated indirectly with tetanic pulses of 30-35 Hz for 1 s every 10 s. Arterial pressure was measured from the carotid artery and breathing was monitored with a thermistor placed inside a tracheal cannula. The electrocardiogram was recorded from chest leads and heart rate from a cardiotachometer. Simultaneously, effects on autonomic mechanisms were assessed by stimulating at the cervical vagus nerve for 10 s at 10-20 Hz, and measuring the ensuing bradycardia (parasympathetic), and the cervical sympathetic nerve for 60 s and recording the induced contractions of the nictitating membrane. Oesophageal temperature was measured with a probe and maintained at 36-37 = C. Similar techniques were used on beagle dogs of either sex weighing 8.6-14.9 kg and analogous procedures were carried out using rhesus monkeys of 2.8-4.1 kg as described by Hughes and Chappie (1976b) . In monkeys anaesthesia was induced with thiopentone 25 rag kg" ' i.v. and maintained with 50% nitrous oxide in oxygen supplemented by thiopentone 5-12 mg kg"' i.v. when required. Effects on sympathetic mechanisms were investigated by measuring the vasopressor response to carotid occlusion for 10 s. During neuromuscular paralysis ventilation of the lungs of the cats and dogs was with air using a Starling Ideal pump and of the rhesus monkeys with nitrous oxide and oxygen using a Phillips AVI Ventilator.
Interaction with halothane
Initially, dose-response curves for neuromuscular blockade of the single twitch response of the gastrocnemius muscle by atracurium were established in cats anaesthetized with chloralose PHARMACOLOGY OF ATRACURIUM 33 followed 60-90 min later by inhalation of concentrations of 1 or 2% halothane. The same doses were then repeated 30-60 min after beginning the administration of halothane. A cross-over design was adopted in which the sequence of administration I was reversed. In half the cats used, the control dose-response curves for atracurium followed 120 min after the interaction study with halothane.
Cholinesterase inhibition
The enzyme was extracted from human skeletal muscle and prepared as a suspension in phosphate buffer at pH 8. Enzymic activity was measured as described by Ellman and others (1961) using acetylthiocholine 0.5 mmol litre" 1 as substrate. Each drug was tested at a range of concentrations and the results expressed as the concentration causing 50% reduction in the rate of hydrolysis of substrate compared with the non-inhibited controls (IC 50 ).
Haemodynamic studies
These were carried out on open-chest beagle dogs anaesthetized with chloralose using techniques described in detail elsewhere (Hughes, 1971 ). An electromagnetic flow sensor was placed around the root of the ascending aorta to record aortic blood flow and a stiflF polyethylene catheter inserted down the left carotid artery to measure aortic pressure. The flow signal was integrated to obtain cardiac output (less coronary flow) and differentiated to derive maximum acceleration (an index of myocardial contractility). Peripheral vas-1 cular resistance was computed by dividing mean aortic pressure by mean aortic flow.
Inotropic and chronotropic effects were assesed using guineapig atria preparations set up at 35 C C in modified Ringer Z solution bubbled with 95% oxygen and 5% carbon dioxide. The force and frequency of each contraction were recorded with a displacement transducer.
Histamine release
Histamine release was studied in beagle dogs anaesthetized with chloralose. Initially, effects of atracurium, tubocurarine (for comparison) and ' histamine on carotid pressure were established in each dog. I.v. injections of 10 mg kg"' of the H,-receptor antagonist mepyramine and 15 mg kg"' of the H 2 -receptor antagonist burimamide or cimetidine were then given, followed by histamine to ascertain that its vasodepressor response was blocked. The established doses of atracurium and tubocurarine were repeated to determine their effects on carotid pressure during histaminereceptor blockade.
Changes in acid-base balance
Effects of respiratory and metabolic acidosis and alkalosis on neuromuscular blockade of the tetanic and single twitch responses of the gastrocnemius muscles by atracurium were investigated in groups of cats anaesthetized with chloralose using techniques described previously (Hughes, 1970) . Arterial blood was sampled frequently for measurement of pH, Pco 2 and Po 2 . Controlled ventilation was used throughout. I.v. doses of atracurium were given before, during and after the imposed changes in acid-base balance; intervals of 45-85 min were allowed between doses.
Elimination of atracurium
A cannula was placed in a branch of the hepatic portal vein of anaesthetized cats so that atracurium could be administered through the liver. A crossover design was adopted so that half the cats first received increasing doses of atracurium through the hepatic portal vein, after which dose-response curves were obtained for neuromuscular blockade of the single twitch response of the gastrocnemius muscle. After an interval of 120 min from the last dose, when recovery was complete, the same sequence of doses was given through the jugular vein and dose-response curves established for this route; in the other cats the order of administration was reversed.
In other tests, increasing doses of atracurium or gallamine (for comparison) were given to anaesthetized cats to establish dose-response curves for neuromuscular blockade. After an interval of 60 min from the last dose, when recovery was complete, renal function was abolished by ligating the renal artery and vein and ureter of each kidney. Sixty minutes later administration of the same range of doses of atracurium and gallamine was repeated to obtain dose-response curves in the absence of renal function.
Drugs
Solutions of drugs were made in NaCl 9 mg ml" ' and those of atracurium were acidified by addition of one drop of acetic acid 2 mol litre"' to 2-A ml of solution to maintain pH in the optimum range of stability. Doses stated are those 34 BRITISH JOURNAL OF ANAESTHESIA of the dibesylate salt of atracurium, the dibromide of dimethyltubocurarine, fazadinium and pancuronium, the chloride of edrophonium and acetylthiocholine, the dichloride of alcuronium, suxamethonium and tubocurarine, the di-iodide of decamethonium, the hydrochloride of cimetidine, the tri-ethiodide of gallamine, the maleate of mepyramine, the methylsulphate of neostigmine, the acid phosphate of histamine, the sulphate of physostigmine. A solution of burimamide was obtained by suspending the drug in 0.9% sodium chloride and acidifying with a minimal volume of HC1 lmol litre" 1 .
Analysis of results
Statistical analysis was with Student's t-tests.
RESULTS

Neuromuscular studies
Bath concentrations of atracurium 0.5-1.0 ug ml" ', like those of other competitive Atracurium 0.25 mg kg' 1 iv
Carotid pressure agents tubocurarine (0.5-1.0 ug ml l ) and gallamine (lOugml" 1 ), caused blockade of the isolated chick biventer-cervicis preparation without producing an initial contracture. The block was antagonized by physostigmine 2 ug ml" 'and edrophonium 2ugml~1 and reversed by washing out the bath medium and refilling with fresh Krebs solution. In contrast the blocking action of the depolarizing drugs, suxamethonium 0.1 ugml" 1 and decamethonium 0.05 ug ml" \ was preceded by an initial contracture. Blockade was potentiated by edrophonium but reversed by washing out.
In anaesthetized cats, i.v. doses of atracurium 0.25 mg kg" 1 were sufficient to cause complete neuromuscular blockade of the single twitch and tetanic responses of the gastrocnemius muscle and to arrest breathing ( fig. 2) . The results in cats, and those in dogs and rhesus monkeys, are summarized in table I. The dose estimated to produce 50% paralysis shows that, for each species studied, the tetanic response was significantly more sensitive to 200 100 0
Heart rate
Resp
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Gastrocnemius twitches 0.1 Hz atracurium was readily antagonized by neostigmine 0.05 mgkg" 1 i.v. and by edrophonium 0.2 mg kg"' i.v. Figure 3 shows a typical antagonism by neostigmine in an anaesthetized cat. Recovery from atracurium was compared with that from established competitive blocking agents using rate constants for recovery of the peak tetanic contraction in rhesus monkeys (table II) . These rate constants show that recovery from neuromuscular blockade by atracurium was significantly faster than that from tubocurarine and dimethyl tubocurarine, but was comparable to recovery from pancuronium and fazadinium. Although the rate constants for gallamine and alcuronium were less than that for atracurium, the differences were not significant.
Interaction with halothane
In dose-response curves obtained from four anaesthetized cats, the doses of atracurium estimated to produce 50% neuromuscular paralysis were 0.110 ±0.007 mgkg" 1 i.v. in the presence of 1% halothane and 0.142±0.016 mgkg" 1 i.v. in controls without halothane. The value for 2% halothane was 0.130±0.032 mg kg"' i.v.; control 0.183 ±0.035 mg kg"' i.v. These results for both 1 and 2% halothane were not significantly different from the respective controls. Although the mean time taken for recovery after complete blocking doses of atracurium 0.25-0.5 mgkg" 1 i.v. was increased from 22±2.6min to 32+3.3 min with 1% halothane and from 24 ±3.6 min to 51 ±18.5 min with 2% halothane, differences from the controls did not achieve significance.
Cholinesterase inhibition
The IC J0 (umol litre"') values for inhibition of human cholinesterase with acetylthiocholine as substrate, for neostigmine, atracurium and known neuromuscular blocking agents were: neostigmine, <1; fazadinium, 2; pancuronium, 14; alcuronium, 55; atracurium, 56; tubocurarine, 140; gallamine, 900; dimethyl tubocurarine, 1000.
The inhibitory activity of atracurium was less than that of neostigmine, fazadinium and pancuronium, but greater than that of tubocurarine, gallamine and dimethyl tubocurarine.
Autonomic and cardiovascular effects
Recordings from an anaesthetized cat ( fig. 2) show that the bradycardia induced by vagal nerve stimulation, and the contraction of the nictitating membrane in response to sympathetic stimulation, were unimpaired after a dose of atracurium 0.25 mg kg"' i.v. Dose-response curves for atracurium obtained from the results in anaesthetized cats, dogs and rhesus monkeys demonstrate that there is a wide separation between the doses required for neuromuscular paralysis and those that inhibit autonomic mechanisms. For example, figure 4 shows that atracurium caused appreciable vagal blockade only at doses 16 times the full neuromuscular paralysing dose in seven anaesthetized rhesus monkeys and that impairment of sympathetic function was minimal. Results in six anaesthetized cats and four anaesthetized dogs were similar.
In table III the doses required to produce 50% vagal block and 50% neuromuscular block have been estimated from the dose-response curves obtained from six anaesthetized cats and the ratios of these doses have been calculated. Results for known competitive neuromuscular blocking agents, quoted for comparison, have been reported previously (Hughes and Chappie, 1976a, b) . There was a wide separation between the vagal and neuromuscular blocking doses for atracurium and dimethyl tubocurarine. For pancuronium and alcuronium, the separation between these doses was significantly less than that for atracurium and the separation had virtually disappeared for tubocurarine. In contrast, vagal blockade with gallamine and fazadinium occurred with doses less than those required for neuromuscular paralysis.
The lack of cardiovascular effect is illustrated in figure 2, which shows a tracing from an anaesthetized cat given atracurium 0.25 mg kg"' i.v. The small transient changes in arterial pressure and heart rate were probably an artefact associated with the bolus injection and the commencement of artificial ventilation. The wide separation between the neuromuscular and cardiovascular effects of atracurium in six anaesthetized cats is shown in figure 5 . Small insignificant increases in mean arterial pressure occurred after doses of 0.125-1 mg kg" 1 ; heart rate was unchanged. Significant hypotension and slight bradycardia were evident after 4 mgkg" 1 i.v., but this dose was 16 times that required for full neuromuscular paralysis. Similar results were obtained in seven anaesthetized rhesus monkeys. In four anaesthetized dogs, atracurium 2 mg kg"' i.v. reduced mean arterial pressure to 53 ±20.2% of the control value, but this dose was eight times that required for full neuromuscular paralysis.
Experiments were carried out orvfour anaesthetized beagle dogs, allowed to recover fully after receiving excessive doses of atracurium. Each of two dogs received 2.5 mg kg" ' i.v., 10 times the dose required for full neuromuscular paralysis. Apnoea developed rapidly and artificial ventilation was required for 76 and 79 min respectively. Heart rate was reduced by 14 and 23% of control and the P and T waves of the electrocardiogram were reduced. The pupils were still responsive to light and no salivation was observed. Both dogs made an uneventful recovery after termination of anaesthesia. Each of the other two dogs, with an implanted aortic catheter for recording arterial pressure, received doses of atracurium 0.25, 0.5, 1.0 and 2-Omgkg" 1 i.v. (3.75 mgkg" 1 total). These doses caused apnoea and artificial ventilation of the lungs was required for a mean 23,48, 66 and 87 min respectively. The corresponding period indicates the time required for recovery after each dose. Cardiovascular effects were minimal after 0.25 and 0.5 mgkg" 1 i.v., but the following changes occurred after doses of 1 and 2 mg kg"' i.v. (i.e. four and eight times the full neuromuscular paralysing dose); in one dog mean aortic pressure was markedly reduced by 45 and 68% of control respectively and heart rate was slightly reduced by 15 and 7 %. The QRS complex of the electrocardiogram was reduced and the T wave enlarged. After the same doses in the other dog, mean aortic pressure was reduced by 15 and 10% respectively and heart rate was increased by 20 and 21% of control. The P wave of the electrocardiogram was enlarged. In both dogs salivation occurred. Although breathing was fully restored after the last dose of atracurium, neostigmine 0.5 mg i.v. preceded by atropine 0.3 or 0.6 mg i.v., was given to ensure adequate reversal of the neuromuscular blockade. Both dogs made an uneventful recovery after termination of anaesthesia.
Haemodyncomc studies
In each of five anaesthetized dogs i.v. doses of atracurium 0.0625 and 0.125 mgkg" 1 had no important effects on the circulatory variables shown in table IV, including central venous pressure (not tabulated). Doses of 0.25, 0.5 and 1.0 mg kg"' i.v. slightly reduced phasic aortic flow, mean aortic pressure, heart rate, cardiac output and peripheral resistance. Maximum acceleration was reduced only by 1.0 mg kg~' i.v. Central venous pressure was virtually unchanged; the T wave of the electrocardiogram was slightly enlarged. These small circulatory effects persisted for 5-60 min.
A dose of 2.0 mg kg"' i.v. (eight times the full neuromuscular paralysing dose) reduced phasic aortic flow, mean aortic pressure, heart rate, cardiac output, maximum acceleration and peripheral resistance. Central venous pressure was slightly increased; the T wave of the electrocardiogram was enlarged. One dog died after 28 min and a postmortem revealed atrophy of the right ventricle. In the four surviving dogs the circulatory effects persisted for about 90 min except for mean aortic pressure which, in two of the four dogs, was still reduced after this period. The four dogs received a further dose of 4.0 mg kg" 1 i.v. which further reduced the circulatory variables; the T wave of the electrocardiogram was enlarged. All these dogs survived and were recovering for 45 min when the experiments were terminated.
In other experiments atracurium, at bath concentrations of 100 ug ml"', had no inotropic or chronotropic effects on spontaneously beating guineapig atria. This concentration is greatly in excess of the blood concentrations of atracurium likely to be encountered after full neuromuscular paralysing doses.
Histamine release
Evidence of histamine release was obtained only after administration of relatively large doses of atracurium to anaesthetized dogs which are known to release histamine readily. Doses of 10 mg kg"' i.v. mepyramine and 15 mg kg"' i.v. burimamide or cimetidine were sufficient to abolish the decrease in mean arterial pressure induced by histamine 20 or 40 ug kg"' i.v. in each of four dogs ( fig. 6 ). Such doses of the H,-and H 2 -receptor antagonists reduced, in part, the moderate hypotension caused by atracurium 2 mg kg"' i.v. and greatly reduced the marked hypotension produced by tubocurarine 0.4 mg kg" ' i.v. It should be noted that the dose of atracurium used was eight times the neuromuscular paralysing dose while that of tubocurarine was, in fact, the paralysing dose in dogs. 
Changes in acid-base balance
During respiratory acidosis, induced by ventilation with 20% carbon dioxide, neuromuscular paralysis of both responses was greater than in the control tests carried out before and after the acidosis, but the increase did not achieve statistical 40 BRITISH JOURNAL OF ANAESTHESIA significance (table V) . However, recovery of both the single twitch and tetanic responses was significantly longer during acidosis. Metabolic acidosis, caused by infusion of 8.4-12.0 mmol of hydrochloric acid 0.75 mol litre"', significantly enhanced blockade of the single twitch and also significantly prolonged recovery of the single twitch and tetanic responses as indicated in table V.
Paralysis of both neuromuscular responses was significantly reduced and recovery significantly shortened during respiratory alkalosis produced by increasing the tidal volume four-fold. Similarly, metabolic alkalosis, caused by infusion of 19.6-27.3 mmol of sodium bicarbonate 1 mol litre" 1 , significantly reduced paralysis of the single twitch and significantly shortened recovery of the tetanic response as shown in table V.
In these experiments effects on paralysis of the tetanically stimulated muscles were obscured by the presence of complete blockade, but changes in recovery times followed those of the contralateral muscles stimulated by single shocks.
Elimination
The role of the liver was studied in four anaesthetized cats. From dose-response curves, the doses of atracurium estimated to produce 50% neuromuscular paralysis were 0.119 ±0.013 mgkg" 1 via the jugular vein and 0.121 ±0.016 mg kg"' via the hepatic portal vein; these values were not significantly different. Furthermore, the mean time taken for full recovery after a complete blocking dose of 0.25 mg kg" ' was similar when atracurium was given through the hepatic portal vein (27.1 ±4.3 min) to that when given through the jugular vein (26.5 + 5.8 min).
The involvement of the kidneys was also studied in four anaesthetized cats. From dose-response curves, the dose of atracurium estimated to produce 50% neuromuscular paralysis, was not significantly changed after renal ligation, whereas that for gallamine was significantly reduced (fig. 7) . Although the mean time taken for recovery after complete blocking doses of atracurium 0.25-0.5 mgkg" 1 i.v. was increased from 29 ±2.9 min to 43 ±9.2 min after renal ligation, the difference did not achieve significance. However, after complete blocking doses of gallamine 0.5-2.0 mgkg" 1 i.v., renal ligation significantly prolonged recovery from 24 ±3.7 min to 79±14.3min(P<0.05). 
DISCUSSION
In a previous study with dimethyl tubocurarine, we concluded that this drug has desirable pharmacological properties, but there remains a need for a neuromuscular blocking agent with a similar highly specific action at the neuromuscular junction but of shorter duration (Hughes and Chappie, 1976b) . It seems from our pharmacological assessment, that atracurium may possess these desirable properties.
The neuromuscular experiments demonstrated that atracurium is a potent competitive neuromuscular blocking agent. Paralysis was readily antagonized by anticholinesterases and, similar to other competitive agents, blockade was enhanced by halothane. The tetanic response was significantly more sensitive to paralysis than the single twitch, but the time taken for recovery from equal block of both responses was similar. It has also been demonstrated, in anaesthetized man, that the tetanic response is a more sensitive index than the single twitch for the assessment of neuromuscular blockade (Hughes, Ingram and Payne, 1976) .
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BRITISH JOURNAL OF ANAESTHESIA Although atracurium was significantly more potent in dogs than in either cats or rhesus monkeys, the time-course of neuromuscular blockade was similar throughout these species. This observation may be important, since it has been reported that the duration of action of some competitive blocking agents was longer in monkeys, as in man, than in other species (Biggs, Davis and Wien, 1964; Mushin and Mapleson, 1964; Bamford et al., 1967; Busfield et al., 1968; Hughes, 1972; Hughes and Chappie, 1976b; Hughes, Payne and Sugai, 1976) . In comparison with established drugs, it was shown that atracurium was intermediate in its course of action. For example, in anaesthetized monkeys, recovery from neuromuscular blockade by atracurium was significantly faster than recovery from tubocurarine and dimethyl tubocurarine, but was comparable to that of other available competitive drugs with a medium duration of action.
Cholinesterase inhibition by atracurium is unlikely to be of importance since IC J0 for the human enzyme corresponds to a concentration of approximately 70ugml~1. This concentration is greatly in excess of that likely to occur after neuromuscular paralysing doses of atracurium.
An important feature of atracurium was the wide separation between doses required for neuromuscular paralysis and those which inhibit autonomic mechanisms. It is well established that vagal blockade in man causes undesirable tachycardia and hypertension. In this respect, the vagolytic effect of atracurium, like that of dimethyl tubocurarine, was substantially less than that of other competitive agents currently used in anaesthetic practice. Unlike tubocurarine, the impairment of sympathetic function was minimal even at supramaximal neuromuscular paralysing doses. However, some consider that inhibition of catecholamine uptake may contribute in part to the cardiovascular effects associated with administration of pancuronium (Ivankovich et al., 1975; Docherty and McGrath, 1977) . Dr L. G. Garland of our laboratories has carried out a preliminary study of catecholamine uptake using perfused rat hearts similar to that described by Iversen (1963) and used recently by Salt, Barnes and Conway (1980) for experiments with pancuronium analogues. It was found that atracurium partially blocked both uptake processes, but only at concentrations in excess of those likely to occur after neuromuscular paralysing doses. Uptake 2 was inhibited more strongly than Uptake,; the corresponding ICj 0 values were 20ngml~1 and 100 ug ml ~' respectively. No doubt the absence of effect on the various autonomic mechanisms has contributed to the cardiovascular stability associated with atracurium. Significant hypotension and slight bradycardia occurred only with doses 16 times that required for full neuromuscular paralysis in anaesthetized cats and rhesus monkeys and in dogs circulatory depression only became of importance at eight times this dose. In vitro atrial preparations indicated the absence of direct inotropic and chronotropic effects. Indirect evidence obtained from anaesthetized dogs suggests that the cardiovascular effects of atracurium were attributable mainly to histamine release; unlike tubocurarine, such effects occurred only after doses of atracurium eight times the full neuromuscular paralysing dose. However, since the hypotensive action of atracurium was not completely blocked by H]-and H 2 -receptor antagonists, sympathetic blockade may also play a minor role. The margin of safety with atracurium was also exemplified in those experiments in which very large doses of atracurium were given to anaesthetized dogs which made an uneventful recovery from the neuromuscular blockade and anaesthesia.
In vitro studies, carried out by colleagues in our Central Analytical Laboratories, Dartford, have shown that when atracurium is incubated at 37 °C in buffers of appropriate pH, its non-enzymic decomposition was at least three times faster when the pH was increased from 6.9 to pH 7.6. Analysis of the decomposition products by high performance liquid chromatography verified that this route of inactivation was by "Hofmann Elimination". We may have demonstrated the "Hofmann" mechanism in vivo in anaesthetized cats, since neuromuscular paralysis by atracurium was significantly reduced when the arterial pH was increased by respiratory and metabolic alkalosis; conversely, paralysis was significantly enhanced when the arterial pH was reduced by respiratory and metabolic acidosis.
Experiments in anaesthetized cats indicate that atracurium was not rapidly taken up by the liver, unlike a previous neuromuscular blocker, BW403C65, with which there was a three-fold reduction in its paralysing potency when the compound was given through the hepatic portal vein (Hughes, 1972) . Furthermore, the results after renal ligation indicated that, unlike gal-43 lamine, the kidneys are not a major route for the elimination of unchanged atracurium.
We conclude from this study that the pharmacological properties of atracurium are of sufficient interest to merit its evaluation as a neuromuscular blocking agent in anaesthetized man. sulfuro, forma pane de una nueva serie de competitivos agentcs de bloqueo ncuromuscular. Una dosis intravenosa dc 0^5mgkg"' produjo una paralisis total en gatos, perros y macacos de la India anestesiados; la paralisis fue de duration media y rapidemente contrarrestada por la neostigmina. El bloqueo vagal tuvo lugar tan solo despues de administrar dosis de 8 a 16 veces mayores que la correspondiente a la dosis de paralisis neuromuscular total y los efectos sobre los mecanismos simpaucos fueron minimos. La hipotension y la bradicadia fueron evidentes despues de dosis supramaximas de 4 mg kg"' dc caracter intravenoso, y estos efectos, junto con la depresion circulatoria, pueden seguramente atribuirse a la aparicion de histamina. Los estudios in vitro nan demostrado que la descomposicion no enzimica del atracuriom, mediante la "Eliminacion Hofmann", fue intensificada por el pH creciente. La paralisis neuromuscular in vivo se redujo de forma significative cuando el pH arterial se incremento. Hubo indicaciones de que el higado y el rinon no jucgan un papel importante en el metabolismo ni en la eliminacion de drogas inalteradas. Estos rcsultados son dc suficiente interes como para merecer la evaluacion del atracuriom en el hombre anestesiado.
El atracuriom besilate, con composicion de 2,2-<3,11-dioxo-4, 10-dioxatndecileno)-bis-[6, 7-dimetoxi-1-(3, 4-dimetoxibencilo)-2-metilo-l,23,4-tetrahidroisoquinoliniom] dibenceno de
